类风湿关节炎母亲所生子女的DNA甲基化改变
本研究比较了80例类风湿关节炎(RA)母亲所生子女与354例一般人群儿童的全基因组DNA甲基化,发现147个CpG位点存在差异甲基化;这些差异与母亲孕期RA疾病活动度或用药无关,因果关系尚不明确,需进一步重复验证。
要点
- RA母亲所生子女与对照儿童之间存在147个差异甲基化CpG位点。
- 差异甲基化与母亲孕期RA疾病活动度或用药无关联。
- 差异甲基化的因果关系及其对子代远期健康的影响尚不明确。
核心结论
- RA母亲所生子女与一般人群儿童在147个CpG位点的DNA甲基化存在差异。
- 未发现这些甲基化差异与母亲孕期RA疾病活动度或用药相关。
- 上述关联是否为因果、是否由疾病或治疗所致尚不清楚,需重复研究验证。
研究设计与样本
- 病例对照研究,采用Infinium Illumina HumanMethylation 450K BeadChip检测全基因组CpG位点甲基化。
- 暴露组为80例RA母亲所生子女(平均年龄6.8岁)的血液样本。
- 对照组为354例来自基于人群的Generation R研究的儿童(平均年龄6.0岁)血液样本。
- 采用线性混合模型分析组间差异甲基化,并校正相关混杂因素。
主要发现
- 共147个CpG位点在RA母亲所生子女与对照儿童血液样本间存在差异甲基化。
- 关联最显著的5个CpG位点为cg06642177、cg08867893、cg06778273、cg07786668和cg20116574。
- 甲基化差异与母亲孕期RA疾病活动度或用药无关联。
临床怎么用
- 结果提示RA母亲所生子女可能存在DNA甲基化改变,但尚不足以指导临床决策。
- 孕期RA疾病活动度或用药与子代甲基化差异无关联,暂不支持据此调整孕期管理。
- 需重复验证后方可评估这些甲基化改变对子代远期健康的意义。
局限性
- 原文指出这些关联是否为因果、是否由疾病或治疗所致尚不清楚。
- 原文指出需更多研究包括重复验证,以加强发现对子代远期健康的相关性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The main objective of this study was to determine whether the DNA methylation profile of children born to mothers with rheumatoid arthritis (RA) is different from that of children born to mothers from the general population. In addition, we aimed to determine whether any differences in methylation are associated with maternal RA disease activity or medication use during pregnancy. METHODS: For this study, genome-wide DNA methylation was measured at cytosine-phosphate-guanine (CpG) sites, using the Infinium Illumina HumanMethylation 450K BeadChip, in 80 blood samples from children (mean age=6.8 years) born to mothers with RA. As controls, blood samples from 354 children (mean age=6.0 years) from the population-based Generation R Study were used. Linear mixed models were performed to investigate differential methylation between the groups, corrected for relevant confounders. RESULTS: A total of 147 CpGs were differentially methylated between blood samples of children born to mothers with RA and the control blood samples. The five most significantly associated CpGs were cg06642177, cg08867893, cg06778273, cg07786668 and cg20116574. The differences in methylation were not associated with maternal RA disease activity or medication use during pregnancy. CONCLUSIONS: DNA methylation at 147 CpGs differed between children born to mothers with RA and children born to mothers from the general population. It remains unknown whether the identified associations are causal, and if so whether they are caused by the disease or treatment. More research, including replication of these results, is necessary in order to strengthen the relevance of our findings for the later-life health of children born to mothers with RA.
引用
- Ince-Askan H, Mandaviya PR, Felix JF, et al. Altered DNA methylation in children born to mothers with rheumatoid arthritis during pregnancy. Ann Rheum Dis. 2019. PMID: 31142478. doi:10.1136/annrheumdis-2018-214930
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。